Keyphrases
Type 2 Diabetic Patients
100%
Bladder Cancer
100%
Metformin
100%
Urinary Bladder Cancer
66%
Sulfonylurea
55%
Antidiabetic Drugs
33%
Insulin
22%
Diabetes Duration
22%
Bladder Cancer Risk
22%
Inception Cohort
22%
New-user Design
22%
Cox Proportional Hazards Model
11%
Copyright
11%
Retrospective Cohort Study
11%
Smoking Status
11%
Clinical Practice Research Datalink
11%
Dipeptidyl peptidase-4 (DPP-4)
11%
Follow-up Time
11%
Glitazones
11%
Glinides
11%
Metformin Use
11%
Medicine and Dentistry
Maturity Onset Diabetes of the Young
100%
Bladder Cancer
100%
Glycon
100%
Sulfonylurea
50%
Diabetes
20%
Cancer Risk
20%
Antidiabetic Agent
20%
Proportional Hazards Model
10%
Body Mass Index
10%
Retrospective Cohort Study
10%
Oral Antidiabetic Agent
10%
Dipeptidyl Peptidase-4 Inhibitor
10%
Nursing and Health Professions
Non Insulin Dependent Diabetes Mellitus
100%
Metformin
100%
Bladder Cancer
100%
Sulfonylurea
50%
Antidiabetic Agent
20%
Clinical Practice
10%
Drug Use
10%
Dipeptidyl Peptidase IV Inhibitor
10%
Cohort Analysis
10%
Proportional Hazards Model
10%
Oral Antidiabetic Agent
10%
Pharmacology, Toxicology and Pharmaceutical Science
Bladder Cancer
100%
Metformin
100%
Non Insulin Dependent Diabetes Mellitus
100%
Sulfonylurea
50%
Antidiabetic Agent
20%
Cohort Study
10%
Oral Antidiabetic Agent
10%
Dipeptidyl Peptidase IV Inhibitor
10%
Mathematics
Cox Proportional Hazards Model
100%
Drug User
100%
Smoking Status
100%
Control Group
100%
Engineering
Control Group
100%
Smoking Status
100%